Eigentler, T.K., Hassel, J.C., Berking, C., Aberle, J., Bachmann, O., Grunwald, V., . . . Gutzmer, R. (2016). Diagnosis, monitoring and management of immune-related adverse drug reactions of anti-PD-1 antibody therapy. Cancer Treatment Reviews, 45, 7–18.
RESOURCE TYPE: Expert opinion
PHASE OF CARE: Active antitumor treatment
Review article
Literature review of common anti-PD-1 checkpoint pathway inhibitors/antibody therapy adverse events. No evidence of quality review provided.
Research is needed on the management of anti-PD-1 checkpoint pathway inhibitors/antibody therapy toxicities.